Endovascular treatment of acute ischemic stroke

Neuroimaging Clinics of North America

Volumn 23, Issue 4, 2013, Pages 673-694

  Natarajan, Sabareesh K ^a,b   Eller, Jorge L ^a,b   Snyder, Kenneth V ^a,b   Hopkins, L Nelson ^a,b,c   Levy, Elad I ^a,b   Siddiqui, Adnan H ^a,b  

^a UNIVERSITY AT BUFFALO   (United States)

^b Kaleida Health ^*  (United States)

^c JACOBS INSTITUTE   (United States)

Author keywords

Endovascular treatment; Imaging; Ischemia; Stroke

Indexed keywords

ALTEPLASE; EPTIFIBATIDE; GLYCERYL TRINITRATE; NITINOL;

BLOOD CLOT LYSIS; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; BRAIN PERFUSION; CLINICAL ASSESSMENT TOOL; CLINICAL EFFECTIVENESS; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFICACY; ENDOVASCULAR SURGERY; EQUIPMENT DESIGN; FIBRINOLYTIC THERAPY; FOLLOW UP; GUIDE WIRE; HUMAN; INTRAVASCULAR CATHETER; MECHANICAL THROMBECTOMY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROIMAGING; OUTCOME ASSESSMENT; PATIENT SAFETY; PATIENT SELECTION; PERCUTANEOUS THROMBECTOMY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECANALIZATION; REVASCULARIZATION; REVIEW; SCORING SYSTEM; THROMBOLYSIS IN MYOCARDIAL INFARCTION SCORE; VASCULAR STENT;

ENDOVASCULAR TREATMENT; IMAGING; ISCHEMIA; STROKE;

CEREBRAL REVASCULARIZATION; COMBINED MODALITY THERAPY; ENDOVASCULAR PROCEDURES; FIBRINOLYTIC AGENTS; HUMANS; INFUSIONS, INTRAVENOUS; MECHANICAL THROMBOLYSIS; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84885952851     PISSN: 10525149     EISSN: 15579867     Source Type: Journal    
DOI: 10.1016/j.nic.2013.03.014     Document Type: Review

References (103)

1. Barber P.A., Zhang J., Demchuk A.M., et al. Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility. Neurology 2001, 56(8):1015-1020.
2. Hacke W., Kaste M., Bluhmki E., et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. NEngl J Med 2008, 359(13):1317-1329.
3. Alexandrov A.V., Grotta J.C. Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator. Neurology 2002, 59(6):862-867.
4. Janjua N., Alkawi A., Suri M.F., et al. Impact of arterial reocclusion and distal fragmentation during thrombolysis among patients with acute ischemic stroke. AJNR Am J Neuroradiol 2008, 29(2):253-258.
5. Saqqur M., Molina C.A., Salam A., et al. Clinical deterioration after intravenous recombinant tissue plasminogen activator treatment: a multicenter transcranial Doppler study. Stroke 2007, 38(1):69-74.
6. Natarajan S.K., Karmon Y., Snyder K.V., et al. Prospective acute ischemic stroke outcomes after endovascular therapy: a real-world experience. World Neurosurg 2010, 74(4-5):455-464.
7. IMS Investigators Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study. Stroke 2004, 35(4):904-911.
8. Jaillard A., Cornu C., Durieux A., et al. Hemorrhagic transformation in acute ischemic stroke. The MAST-E study. MAST-E Group. Stroke 1999, 30(7):1326-1332.
9. Tanne D., Kasner S.E., Demchuk A.M., et al. Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the Multicenter rt-PA Stroke Survey. Circulation 2002, 105(14):1679-1685.
10. Wolpert S.M., Bruckmann H., Greenlee R., et al. Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. The rt-PA Acute Stroke Study Group. AJNR Am J Neuroradiol 1993, 14(1):3-13.
11. Saqqur M., Uchino K., Demchuk A.M., et al. Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke. Stroke 2007, 38(3):948-954.
12. Arnold M., Nedeltchev K., Mattle H.P., et al. Intra-arterialthrombolysis in 24 consecutive patients with internal carotid artery T occlusions. JNeurol Neurosurg Psychiatry 2003, 74(6):739-742.
13. Jansen O., von Kummer R., Forsting M., et al. Thrombolytic therapy in acute occlusion of the intracranial internal carotid artery bifurcation. AJNR Am J Neuroradiol 1995, 16(10):1977-1986.
14. Sorimachi T., Fujii Y., Tsuchiya N., et al. Recanalization by mechanical embolus disruption during intra-arterial thrombolysis in the carotid territory. AJNR Am J Neuroradiol 2004, 25(8):1391-1402.
15. Zaidat O.O., Suarez J.I., Santillan C., et al. Response to intra-arterial and combined intravenous and intra-arterial thrombolytic therapy in patients with distal internal carotid artery occlusion. Stroke 2002, 33(7):1821-1826.
16. Barreto A.D., Albright K.C., Hallevi H., et al. Thrombus burden is associated with clinical outcome after intra-arterial therapy for acute ischemic stroke. Stroke 2008, 39(12):3231-3235.
17. Gralla J., Burkhardt M., Schroth G., et al. Occlusion length is a crucial determinant of efficiency and complication rate in thrombectomy for acute ischemic stroke. AJNR Am J Neuroradiol 2008, 29(2):247-252.
18. Kim Y.S., Garami Z., Mikulik R., et al. Early recanalization rates and clinical outcomes in patients with tandem internal carotid artery/middle cerebral artery occlusion and isolated middle cerebral artery occlusion. Stroke 2005, 36(4):869-871.
19. Mattle H.P., Arnold M., Georgiadis D., et al. Comparison of intraarterial and intravenous thrombolysis for ischemic stroke with hyperdense middle cerebral artery sign. Stroke 2008, 39(2):379-383.
20. Puetz V., Dzialowski I., Hill M.D., et al. Intracranial thrombus extent predicts clinical outcome, final infarct size and hemorrhagic transformation in ischemic stroke: the clot burden score. Int J Stroke 2008, 3(4):230-236.
21. Somford D.M., Nederkoorn P.J., Rutgers D.R., et al. Proximal and distal hyperattenuating middle cerebral artery signs at CT: different prognostic implications. Radiology 2002, 223(3):667-671.
22. Fischer U., Arnold M., Nedeltchev K., et al. NIHSS score and arteriographic findings in acute ischemic stroke. Stroke 2005, 36(10):2121-2125.
23. Maas M.B., Furie K.L., Lev M.H., et al. National Institutes of Health Stroke Scale score is poorly predictive of proximal occlusion in acute cerebral ischemia. Stroke 2009, 40(9):2988-2993.
24. Gobin Y.P., Starkman S., Duckwiler G.R., et al. MERCI 1: a phase 1 study of mechanical embolus removal in cerebral ischemia. Stroke 2004, 35(12):2848-2854.
25. Smith W.S., Sung G., Starkman S., et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005, 36(7):1432-1438.
26. Smith W.S., Sung G., Saver J., et al. Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke 2008, 39(4):1205-1212.
27. Tomsick T., Broderick J., Carrozella J., et al. Revascularization results in the Interventional Management of Stroke II trial. AJNR Am J Neuroradiol 2008, 29(3):582-587.
28. Rha J.H., Saver J.L. The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke 2007, 38(3):967-973.
29. Lansberg M.G., Bluhmki E., Thijs V.N. Efficacy andsafety of tissue plasminogen activator 3- to 4.5-hours after acute ischemic stroke. A metaanalysis. Stroke 2009, 40:2438-2441.
30. Wardlaw J.M., Sandercock P.A., Berge E. Thrombolytic therapy with recombinant tissue plasminogen activator for acute ischemic stroke: where do we go from here? A cumulative meta-analysis. Stroke 2003, 34(6):1437-1442.
31. del Zoppo G.J., Higashida R.T., Furlan A.J., et al. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism. Stroke 1998, 29(1):4-11.
32. Furlan A., Higashida R., Wechsler L., et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999, 282(21):2003-2011.
33. Bose A., Henkes H., Alfke K., et al. The Penumbra System: a mechanical device for the treatment of acute stroke due to thromboembolism. AJNR Am J Neuroradiol 2008, 29(7):1409-1413.
34. Hacke W., Albers G., Al-Rawi Y., et al. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 2005, 36(1):66-73.
35. Furlan A.J., Eyding D., Albers G.W., et al. Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9hours after stroke onset. Stroke 2006, 37(5):1227-1231.
36. Thomalla G., Schwark C., Sobesky J., et al. Outcome and symptomatic bleeding complications of intravenous thrombolysis within 6 hours in MRI-selected stroke patients: comparison of a German multicenter study with the pooled data of ATLANTIS, ECASS, and NINDS tPA trials. Stroke 2006, 37(3):852-858.
37. Kohrmann M., Juttler E., Fiebach J.B., et al. MRI versus CT-based thrombolysis treatment within and beyond the 3 h time window after stroke onset: a cohort study. Lancet Neurol 2006, 5(8):661-667.
38. Davis S.M., Donnan G.A., Parsons M.W., et al. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol 2008, 7(4):299-309.
39. Hacke W., Furlan A.J., Al-Rawi Y., et al. Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study. Lancet Neurol 2009, 8(2):141-150.
40. Jovin T.G., Liebeskind D.S., Gupta R., et al. Imaging-based endovascular therapy for acute ischemic stroke due to proximal intracranial anterior circulation occlusion treated beyond 8 hours from time last seenwell: retrospective multicenter analysis of 237 consecutive patients. Stroke 2011, 42(8):2206-2211.
41. Bozzao L., Fantozzi L.M., Bastianello S., et al. Early collateral blood supply and late parenchymal brain damage in patients with middle cerebral artery occlusion. Stroke 1989, 20(6):735-740.
42. Hendrikse J., Hartkamp M.J., Hillen B., et al. Collateral ability of the circle of Willis in patients with unilateral internal carotid artery occlusion: border zone infarcts and clinical symptoms. Stroke 2001, 32(12):2768-2773.
43. Liebeskind D.S. Collateral circulation. Stroke 2003, 34(9):2279-2284.
44. Shuaib A., Butcher K., Mohammad A.A., et al. Collateral blood vessels in acute ischaemic stroke: a potential therapeutic target. Lancet Neurol 2011, 10(10):909-921.
45. Liebeskind D.S., Kim D., Starkman S., et al. Collateral failure? Late mechanical thrombectomy after failed intravenous thrombolysis. JNeuroimaging 2010, 20(1):78-82.
46. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. NEngl J Med 1995, 333(24):1581-1587.
47. Barber P.A., Demchuk A.M., Zhang J., et al. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. Lancet 2000, 355(9216):1670-1674.
48. Parsons M.W., Pepper E.M., Chan V., et al. Perfusion computed tomography: prediction of final infarct extent and stroke outcome. Ann Neurol 2005, 58(5):672-679.
49. Albers G.W., Thijs V.N., Wechsler L., et al. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution (DEFUSE) study. Ann Neurol 2006, 60(5):508-517.
50. Loh Y., Towfighi A., Liebeskind D.S., et al. Basal ganglionic infarction before mechanical thrombectomy predicts poor outcome. Stroke 2009, 40(10):3315-3320.
51. Lui Y.W., Tang E.R., Allmendinger A.M., et al. Evaluation of CT perfusion in the setting of cerebral ischemia: patterns and pitfalls. AJNR Am J Neuroradiol 2010, 31(9):1552-1563.
52. Abou-Chebl A. Endovascular treatment of acute ischemic stroke may be safely performed with no time window limit in appropriately selected patients. Stroke 2010, 41(9):1996-2000.
53. Natarajan S.K., Snyder K.V., Siddiqui A.H., et al. Safety and effectiveness of endovascular therapy after 8hours of acute ischemic stroke onset and wake-up strokes. Stroke 2009, 40(10):3269-3274.
54. Hellier K.D., Hampton J.L., Guadagno J.V., et al. Perfusion CT helps decision making for thrombolysis when there is no clear time of onset. JNeurol Neurosurg Psychiatry 2006, 77(3):417-419.
55. Wintermark M., Fischbein N.J., Smith W.S., et al. Accuracy of dynamic perfusion CT with deconvolution in detecting acute hemispheric stroke. AJNR Am J Neuroradiol 2005, 26(1):104-112.
56. Eastwood J.D., Lev M.H., Azhari T., et al. CT perfusion scanning with deconvolution analysis: pilot study in patients with acute middle cerebral artery stroke. Radiology 2002, 222(1):227-236.
57. Miles K.A., Griffiths M.R. Perfusion CT: a worthwhile enhancement?. Br J Radiol 2003, 76(904):220-231.
58. Wintermark M., Albers G.W., Alexandrov A.V., et al. Acute stroke imaging research roadmap. Stroke 2008, 39(5):1621-1628.
59. Wintermark M., Flanders A.E., Velthuis B., et al. Perfusion-CT assessment of infarct core and penumbra: receiver operating characteristic curve analysis in 130 patients suspected of acute hemispheric stroke. Stroke 2006, 37(4):979-985.
60. Murphy B.D., Fox A.J., Lee D.H., et al. Identification of penumbra and infarct in acute ischemic stroke using computed tomography perfusion-derived blood flow and blood volume measurements. Stroke 2006, 37(7):1771-1777.
61. Sanelli P.C., Lev M.H., Eastwood J.D., et al. The effect of varying user-selected input parameters on quantitative values in CT perfusion maps. Acad Radiol 2004, 11(10):1085-1092.
62. Meyers P.M., Schumacher H.C., Higashida R.T., et al. Indications for the performance of intracranial endovascular neurointerventional procedures: a scientific statement from the American Heart Association Council on Cardiovascular Radiology and Intervention, Stroke Council, Council on Cardiovascular Surgery and Anesthesia, Interdisciplinary Council on Peripheral Vascular Disease, and Interdisciplinary Council on Quality of Care and Outcomes Research. Circulation 2009, 119(16):2235-2249.
63. Inoue T., Kimura K., Minematsu K., et al. Acase-control analysis of intra-arterial urokinase thrombolysis in acute cardioembolic stroke. Cerebrovasc Dis 2005, 19(4):225-228.
64. Ogawa A., Mori E., Minematsu K., et al. Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke: the Middle Cerebral Artery Embolism Local Fibrinolytic Intervention Trial (MELT) Japan. Stroke 2007, 38(10):2633-2639.
65. Urbach H., Hartmann A., Pohl C., et al. Local intra-arterial thrombolysis in the carotid territory: does recanalization depend on the thromboembolus type?. Neuroradiology 2002, 44(8):695-699.
66. IMS Investigators The Interventional Management of Stroke (IMS) II Study. Stroke 2007, 38(7):2127-2135.
67. Khatri P., Hill M.D., Palesch Y.Y., et al. Methodology of the Interventional Management of Stroke III Trial. Int J Stroke 2008, 3(2):130-137.
68. Barnwell S.L., Clark W.M., Nguyen T.T., et al. Safety and efficacy of delayed intraarterial urokinase therapy with mechanical clot disruption for thromboembolic stroke. AJNR Am J Neuroradiol 1994, 15(10):1817-1822.
69. Gralla J., Schroth G., Remonda L., et al. Adedicated animal model for mechanical thrombectomy in acute stroke. AJNR Am J Neuroradiol 2006, 27(6):1357-1361.
70. Gralla J., Schroth G., Remonda L., et al. Mechanical thrombectomy for acute ischemic stroke: thrombus-device interaction, efficiency, and complications invivo. Stroke 2006, 37(12):3019-3024.
71. Flint A.C., Duckwiler G.R., Budzik R.F., et al. Mechanical thrombectomy of intracranial internal carotid occlusion: pooled results of the MERCI and Multi MERCI Part I trials. Stroke 2007, 38(4):1274-1280.
72. Penumbra Pivotal Stroke Trial Investigators The penumbra pivotal stroke trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke 2009, 40(8):2761-2768.
73. Tarr R., Hsu D., Kulcsar Z., et al. The POST trial: initial post-market experience of the Penumbra system: revascularization of large vessel occlusion in acute ischemic stroke in the United States and Europe. JNeurointerv Surg 2010, 2(4):341-344.
74. Brekenfeld C., Schroth G., Mattle H.P., et al. Stent placement in acute cerebral artery occlusion: use of a self-expandable intracranial stent for acute stroke treatment. Stroke 2009, 40(3):847-852.
75. Levy E.I., Mehta R., Gupta R., et al. Self-expanding stents for recanalization of acute cerebrovascular occlusions. AJNR Am J Neuroradiol 2007, 28(5):816-822.
76. Zaidat O.O., Wolfe T., Hussain S.I., et al. Interventional acute ischemic stroke therapy with intracranial self-expanding stent. Stroke 2008, 39(8):2392-2395.
77. Mocco J., Hanel R.A., Sharma J., et al. Use of a vascular reconstruction device to salvage acute ischemic occlusions refractory to traditional endovascular recanalization methods. JNeurosurg 2010, 112(3):557-562.
78. Levy E.I., Siddiqui A.H., Crumlish A., et al. First Food and Drug Administration-approved prospective trial of primary intracranial stenting for acute stroke: SARIS (Stent-Assisted Recanalization in Acute Ischemic Stroke). Stroke 2009, 40(11):3552-3556.
79. Levy E.I., Rahman M., Khalessi A.A., et al. Midterm clinical and angiographic follow-up for the first Food and Drug Administration-approved prospective, single-arm trial of primary stenting for stroke: SARIS (Stent-Assisted Recanalization for Acute Ischemic Stroke). Neurosurgery 2011, 69(4):915-920.
80. Bose A., Hartmann M., Henkes H., et al. Anovel, self-expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses: the Wingspan study. Stroke 2007, 38(5):1531-1537.
81. Chiam P.T., Samuelson R.M., Mocco J., et al. Navigability trumps all: stenting of acute middle cerebral artery occlusions with a new self-expandable stent. AJNR Am J Neuroradiol 2008, 29(10):1956-1958.
82. Fiorella D., Levy E.I., Turk A.S., et al. US multicenter experience with the Wingspan stent system for the treatment of intracranial atheromatous disease: periprocedural results. Stroke 2007, 38(3):881-887.
83. Hahnel S., Ringleb P., Hartmann M. Treatment of intracranial stenoses using the Neuroform stent system: initial experience in five cases. Neuroradiology 2006, 48(7):479-485.
84. Kurre W., Berkefeld J., Sitzer M., et al. Treatment of symptomatic high-grade intracranial stenoses with the balloon-expandable Pharos stent: initial experience. Neuroradiology 2008, 50(8):701-708.
85. Sauvageau E., Levy E.I. Self-expanding stent-assisted middle cerebral artery recanalization: technical note. Neuroradiology 2006, 48(6):405-408.
86. Kelly M.E., Furlan A.J., Fiorella D. Recanalization of an acute middle cerebral artery occlusion using a self-expanding, reconstrainable, intracranial microstent as a temporary endovascular bypass. Stroke 2008, 39(6):1770-1773.
87. Hauck E.F., Mocco J., Snyder K.V., et al. Temporary endovascular bypass: a novel treatment for acute stroke. AJNR Am J Neuroradiol 2009, 30:1532-1533.
88. Yavuz K., Geyik S., Pamuk A.G., et al. Immediate and midterm follow-up results of using an electrodetachable, fully retrievable SOLO stent system in the endovascular coil occlusion of wide-necked cerebral aneurysms. JNeurosurg 2007, 107(1):49-55.
89. Natarajan S.K., Siddiqui A.H., Hopkins L.N., et al. Retrievable, detachable stent-platform-based clot-retrieval device (Solitaire™ FR) for acute stroke revascularization: first demonstration of feasibility in a canine stroke model. Vascular Disease Management 2010, 7:E120-E125.
90. Cohen J.E., Gomori J.M., Leker R.R., et al. Preliminary experience with the use of self-expanding stent as a thrombectomy device in ischemic stroke. Neurol Res 2011, 33(4):439-443.
91. Miteff F., Faulder K.C., Goh A.C., et al. Mechanical thrombectomy with a self-expanding retrievable intracranial stent (Solitaire AB): experience in 26 patients with acute cerebral artery occlusion. AJNR Am J Neuroradiol 2011, 32:1078-1081.
92. Saver J.L., Jahan R., Levy E.I., et al. Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet 2012, 380:1241-1249.
93. Nogueira R.G., Levy E.I., Gounis M., et al. The Trevo device: preclinical data of a novel stroke thrombectomy device in two different animal models of arterial thrombo-occlusive disease. JNeurointerv Surg 2012, 4(4):295-300.
94. Nogueira R.G., Lutsep H.L., Gupta R., et al. Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial. Lancet 2012, 380:1231-1240.
95. Broderick J.P., Palesch Y.Y., Demchuk A.M., et al. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med 2013, 368:893-903.
96. Kidwell C.S., Jahan R., Gornbein J., et al. A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med 2013, 368:914-923.
97. Ciccone A., Valvassori L., Nichelatti M., et al. Endovascular treatment for acute ischemic stroke. N Engl J Med 2013, 368:904-913.
98. Dabitz R., Triebe S., Leppmeier U., et al. Percutaneous recanalization of acute internal carotid artery occlusions in patients with severe stroke. Cardiovasc Intervent Radiol 2007, 30(1):34-41.
99. Jovin T.G., Gupta R., Uchino K., et al. Emergent stenting of extracranial internal carotid artery occlusion in acute stroke has a high revascularization rate. Stroke 2005, 36(11):2426-2430.
100. Lavallee P.C., Mazighi M., Saint-Maurice J.P., et al. Stent-assisted endovascular thrombolysis versus intravenous thrombolysis in internal carotid artery dissection with tandem internal carotid and middle cerebral artery occlusion. Stroke 2007, 38(8):2270-2274.
101. Miyamoto N., Naito I., Takatama S., et al. Urgent stenting for patients with acute stroke due to atherosclerotic occlusive lesions of the cervical internal carotid artery. Neurol Med Chir (Tokyo) 2008, 48(2):49-56.
102. Nikas D., Reimers B., Elisabetta M., et al. Percutaneous interventions in patients with acute ischemic stroke related to obstructive atherosclerotic disease or dissection of the extracranial carotid artery. JEndovasc Ther 2007, 14(3):279-288.
103. Hauck E.F., Natarajan S.K., Ohta H., et al. Emergent endovascular recanalization for cervical internal carotid artery occlusion in patients presenting with acute stroke. Neurosurgery 2011, 69(4):899-907.